BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25641137)

  • 1. [Clinical features and survival analysis of patients with CD20 positive adult B-lineage acute lymphoblastic leukemia].
    Xu H; Wei X; Yin Q; Wang P; Mi R; Ai H; Wang X; Li Y; Zhu X; Zhang Y; Song Y
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jan; 36(1):4-9. PubMed ID: 25641137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical features and survival analysis of patients with CD20 positive adult B-lineage acute lymphoblastic leukemia].
    Ma J; Sun H; Chen SM; Liu LX; Chen SQ; Liu YF; Xie XS; Meng XL; Deng M; Zhang QT; Li T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):477-81. PubMed ID: 20416193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CD20 Expression in Adult Patients with B-lineage Acute Lymphoblastic Leukemia and Its Prognostic Significance].
    Zhou J; Wang J; Liu H; Zheng HF; Ma L; Wang PF; Yan S; Fu CC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):619-22. PubMed ID: 26117004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia.
    Thomas DA; O'Brien S; Jorgensen JL; Cortes J; Faderl S; Garcia-Manero G; Verstovsek S; Koller C; Pierce S; Huh Y; Wierda W; Keating MJ; Kantarjian HM
    Blood; 2009 Jun; 113(25):6330-7. PubMed ID: 18703706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CD20 is not a poor prognostic factor for childhood B-lineage acute lymphoblastic leukemia with high white blood cell count].
    Zhang LY; Chen XJ; Wang SC; Guo Y; Yang WY; Chen YM; Zhang L; Zou Y; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):728-733. PubMed ID: 32669169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.
    Maury S; Huguet F; Leguay T; Lacombe F; Maynadié M; Girard S; de Labarthe A; Kuhlein E; Raffoux E; Thomas X; Chevallier P; Buzyn A; Delannoy A; Chalandon Y; Vernant JP; Rousselot P; Macintyre E; Ifrah N; Dombret H; Béné MC;
    Haematologica; 2010 Feb; 95(2):324-8. PubMed ID: 19773266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of CD20 in B-cell precursor acute lymphoblastic leukemia and its correlation with clinical outcomes].
    Chen XX; Yuan LX; Zhang G; Wan CM; Huo WY; Tang X; Ai Y; Wan Z; Zhu YP; Gao J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):658-63. PubMed ID: 25286695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic value.
    Solano-Genesta M; Tarín-Arzaga L; Velasco-Ruiz I; Lutz-Presno JA; González-Llano O; Mancías-Guerra C; Rodríguez-Romo L; Ruiz-Delgado GJ; Ruiz-Argüelles GJ; Jaime-Pérez JC; Gómez-Almaguer D
    Hematology; 2012 Mar; 17(2):66-70. PubMed ID: 22664043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
    Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemia.
    Jeha S; Behm F; Pei D; Sandlund JT; Ribeiro RC; Razzouk BI; Rubnitz JE; Hijiya N; Howard SC; Cheng C; Pui CH
    Blood; 2006 Nov; 108(10):3302-4. PubMed ID: 16896151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of adult Philadelphia chromosome-positive acute lymphoblastic leukemia with p16 gene deletion].
    He BL; Xu N; Li YL; Pan CY; Cao R; Liao LB; Yin CX; Lan YQ; Lu ZY; Huang JX; Zhou HS; Liu QF; Liu XL
    Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):204-209. PubMed ID: 28395443
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic Effect of CD20 Expression in Adult B-cell Acute Lymphoblastic Leukemia.
    Esteban RE; Christianne B; Alvaro A; Demichelis-Gómez R
    Clin Lymphoma Myeloma Leuk; 2018 May; 18(5):361-367. PubMed ID: 29544762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of CD20-positive Adult B-cell Acute Lymphoblastic Leukemia and the Impact of Rituximab Therapy.
    Alduailej H; Kanfar S; Bakhit K; Raslan H; Alsaber A; Bashawri L; Aldayel A; Alanezi K
    Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):e560-e568. PubMed ID: 32600932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of CD20 antigen expression among paediatric patients with B-lineage acute lymphoblastic leukaemia.
    Bommannan K; Arumugam JR; Radhakrishnan V; Sundersingh S
    Br J Haematol; 2024 Apr; 204(4):1367-1374. PubMed ID: 38444113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of Clinical Outcomes between P190 and P210 Trans-cripts in Adult Ph Chromosome Positive Acute Lymphoblastic Leukemia in the New Era of TKI].
    Qiu LL; Lu YJ; Jing Y; Yu L; Liu DH; Wang LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):369-74. PubMed ID: 27150994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease.
    Mannelli F; Gianfaldoni G; Intermesoli T; Cattaneo C; Borlenghi E; Cortelazzo S; Cavattoni I; Pogliani EM; Fumagalli M; Angelucci E; Romani C; Ciceri F; Corti C; Scattolin A; Cortelezzi A; Mattei D; Audisio E; Spinelli O; Oldani E; Bosi A; Rambaldi A; Bassan R
    Haematologica; 2012 Apr; 97(4):568-71. PubMed ID: 22058217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD20 expression sub-stratifies standard-risk patients with B cell precursor acute lymphoblastic leukemia.
    Yang S; Wang J; Zhao T; Jia J; Zhu H; Jiang H; Lu J; Jiang B; Shi H; Liu Y; Lai Y; Xu L; Huang X; Jiang Q
    Oncotarget; 2017 Dec; 8(62):105397-105406. PubMed ID: 29285259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia.
    Maury S; Chevret S; Thomas X; Heim D; Leguay T; Huguet F; Chevallier P; Hunault M; Boissel N; Escoffre-Barbe M; Hess U; Vey N; Pignon JM; Braun T; Marolleau JP; Cahn JY; Chalandon Y; Lhéritier V; Beldjord K; Béné MC; Ifrah N; Dombret H;
    N Engl J Med; 2016 Sep; 375(11):1044-53. PubMed ID: 27626518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Xu N; Li YL; Li X; Zhou X; Cao R; Li H; Li L; Lu ZY; Huang JX; Fan ZP; Huang F; Zhou HS; Zhang S; Liu Z; Zhu HQ; Liu QF; Liu XL
    J Hematol Oncol; 2016 Apr; 9():40. PubMed ID: 27090891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen Expression on Blast Cells and Hematological Parameters at Presentation in Acute Lymphoblastic Leukemia Patients.
    Naeem S; Bukhari MH
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):407-11. PubMed ID: 26100991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.